Dicopanol Dailymed
Generic: diphenhydramine hydrochloride
Go PRO for all pill images
Principal Display Panel
Do not use if safety seal is broken NDC 43093-104-01 Rx only FusePaq™  Oral Suspension Kit DICOPANOL™ (diphenhydramine hydrochloride 5 mg/mL, in oral suspension kit) Description: This kit contains active and inactive bulk materials to prepare 150 mL of a diphenhydramine hydrochloride oral suspension containing 5 mg/mL diphenhydramine hydrochloride. This kit may only be used for the extemporaneous combining of these ingredients by an appropriate licensed medical professional in response to a physician's prescription to create a medication tailored to the specialized needs of an individual patient. Active Ingredient:
- 0.75 g diphenhydramine hydrochloride, USP
Inactive Ingredients:
- 150 mL oral suspension vehicle (water, glycerin, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, citric acid, sodium citrate, melatonin, potassium sorbate, sodium benzoate)
- Press-in bottle adaptor for oral dispenser
- Oral dispenser
- Instructions
Store kit at room temperature, 15-30 degrees C (59-86 degrees F) U.S. Patents Pending  FUSION PHARMACEUTICALS  786 Calle Plano Camarillo CA 93012 CS68-A1 rev 2
Drug Label
Do not use if safety seal is broken
Diphenhydramine Hydrochloride Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride Rx Only CAS# 147-24-0 Net contents: 0.75 g Repackaged by: Fusion Pharmaceuticals, LLC Camarillo, CA 93012 CS65-A1 rev 1
Suspension Label
Do not use if safety seal is broken Oral Suspension Vehicle Sugar, dye, and paraben free Ingredients: water, glycerin, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, citric acid, sodium citrate, melatonin, potassium sorbate, sodium benzoate Net Contents: 150 mL (5.1 fl oz) Manufactured for: Fusion Pharmaceuticals, LLC Camarillo, CA 93012 CS66-A1 rev 1
Instructions Insert
NDC 43093-104-01 Rx Only FusePaq tm DICOPANOL tm (diphenhydramine hydrochloride 5 mg/mL, oral suspension- kit) FusePaq tm kits provide a convenient approach to rapidly create prescription medications, as all components are pre-measured. This kit is manufactures according to US FDA current Good Manufacturing Practice (cGMP). Description: This kit contains active and inactive bulk materials to create a diphenhydramine hydrochloride oral suspension. These instructions describe how to prepare 150 mL of oral suspension containing 5 mg/mL diphenhydramine hydrochloride. Other concentrations are possible. Exact strength of the resulting final suspension must be defined by the prescriber. Contents: - 0.75 g diphenhydramine hydrochloride, USP - 150 mL oral suspension vehicle (water, glycerin, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, citric acid, sodium citrate, melatonin, potassium sorbate, sodium benzoate) Instructions for the Pharmacist Diphenhydramine hydrochloride, 5 mg/mL oral suspension 1   Remove and Inspect the Contents of the Kit Ensure that the safety seals are present and intact on the diphenhydramine hydrochloride and oral suspension vehicle bottles. If the seals are not intact, do not use the kit. 2   Prepare for Combining Wear gloves and eye protection during combining operations. Remove the seal from the oral suspension bottle. Break the perforated seal and remove the cap from the diphenhydramine hydrochloride bottle. 3   Transfer Diphenhydramine Hydrochloride to the Suspension Bottle Uncap the suspension bottle. Pour a small amount of suspension liquid (approximately one-third to one-half the volume of the diphenhydramine hydrochloride bottle) into the diphenhydramine hydrochloride bottle. Cap the diphenhydramine hydrochloride bottle and shake well several times to dissolve the diphenhydramine hydrochloride powder. Empty the contents into the suspension bottle. Cap and combine the suspension bottle. Repeat this step 3 times. Visually ensure that all of the diphenhydramine hydrochloride has been dissolved and transferred to the suspension bottle. 4   Complete the Combining Process Insert the press-in bottle adaptor into the suspension bottle. Recap the suspension bottle. Shake well by inverting repeatedly several times. 5   Re-label the Resulting Final Suspension Label the resulting final suspension per the pharmacy's standard practice. Remove or obscure the oral suspension vehicle label, since the label is no longer accurate once the resulting final suspension is completed. Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the resulting final suspension between 15-30°C (59-86°F). The resulting final suspension is stable for at least eight weeks, based upon real-time and accelerated stability studies. Each lot of suspension vehicle is tested to meet microbial limits per USP Microbial Limit Test 61. In addition, the suspension vehicle formulation has passed the USP 51 Antimicrobial Effectiveness Test. An oral dispenser is provided in the kit and may be used to facilitate delivery of the suspension. U.S. Patents Pending Manufactured by: Fusion Pharmaceuticals, LLC 768 Calle Plano Camarillo, CA 93012 CS67-A1 rev 1
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
